Analystreport

BioSpecifics Technologies Corp. (NASDAQ: BSTC) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $81.00 price target on the stock.

BIOSPECIFICS TECHNOLOGIES  (BSTC) 
Last biospecifics technologies earnings: 11/8 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: biospecifics.com